The role of the integrin vitronectin receptor, ?v?3 in melanoma metastasis
10.1007/bf00690295
Crossref journal-article
Springer Science and Business Media LLC
Cancer and Metastasis Reviews (297)
Bibliography

Nip, J., & Brodt, P. (1995). The role of the integrin vitronectin receptor, ?v?3 in melanoma metastasis. Cancer and Metastasis Reviews, 14(3), 241–252.

Authors 2
  1. John Nip (first)
  2. Pnina Brodt (additional)
References 101 Referenced 45
  1. Koh HK: Cutaneous melanoma. New England Journal of Medicine 325: 171?182, 1991 (10.1056/NEJM199107183250306) / New England Journal of Medicine by HK Koh (1991)
  2. Armstrong BK, English DR: Epidemiologic studies. In: Balch CM (ed) Cutaneous Melanoma. J.B. Lippincott, Philadelphia, 1992, pp 12?26 / Cutaneous Melanoma by BK Armstrong (1992)
  3. Morton DL, Wong JH, Kirkwood JM, Parker RG: Malignant melanoma. In: Holland JF, Frei EI, Bast RCJ, Kufe DW, Morton DL, Weichselbaum RR (eds) Cancer Medicine. Lea & Febiger, Philadelphia, 1993, pp 1793?1824 / Cancer Medicine by DL Morton (1993)
  4. Balch CM, Houghton A, Peters L: Cutaneous melanoma. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer Principles & Practice of Oncology. J.B. Lippincott Co., Philadelphia, 1993, pp 1499?1542 / Cancer Principles & Practice of Oncology by CM Balch (1993)
  5. Herlyn M: Human melanoma: development and progression. Cancer Metastasis Rev 9: 101?112, 1990 (10.1007/BF00046337) / Cancer Metastasis Rev by M Herlyn (1990)
  6. Clark WHJ, Elder DE, Van Horn M: The biologic forms of malignant melanoma. Human Path 17: 443?450, 1986 (10.1016/S0046-8177(86)80032-6) / Human Path by WHJ Clark (1986)
  7. Clark WHJ, Elder DE, Guerry DI, Epstein MN, Greene MH, Van Horn M: A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Human Path 15: 1147?1165, 1984 (10.1016/S0046-8177(84)80310-X) / Human Path by WHJ Clark (1984)
  8. Clark WHJ: Tumor progression and the nature of cancer. Br J Cancer 64: 631?644, 1991 (10.1038/bjc.1991.375) / Br J Cancer by WHJ Clark (1991)
  9. Shih IM, Herlyn M: Role of growth factors and their receptors in the development and progression of melanoma. J Invest Derm 100: 196?203, 1993 (10.1038/jid.1993.13) / J Invest Derm by IM Shih (1993)
  10. Rodeck U: Growth factor independence and growth regulatory pathways in human melanoma development. Cancer Metastasis Rev 12: 219?226, 1993 (10.1007/BF00665954) / Cancer Metastasis Rev by U Rodeck (1993)
  11. Lu C, Kerbel RS: Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma. Curr Opin Oncol 6: 212?220, 1994 (10.1097/00001622-199403000-00015) / Curr Opin Oncol by C Lu (1994)
  12. Johnson JP, Rothbacher U, Sers C: The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family. Melanoma Res 3: 337?340, 1993 (10.1097/00008390-199310000-00006) / Melanoma Res by JP Johnson (1993)
  13. Johnson JP: Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease. Cancer Metastasis Rev 10: 11?22, 1991 (10.1007/BF00046840) / Cancer Metastasis Rev by JP Johnson (1991)
  14. Pignatelli M, Vessey CJ: Adhesion molecules: novel molecular tools in tumor pathology. Human Path 25: 849?856, 1994 (10.1016/0046-8177(94)90002-7) / Human Path by M Pignatelli (1994)
  15. Klein CE, Steinmayer T, Kaufmann D, Weber L, Brocker EB: Identification of a melanoma progression antigen as integrin VLA-2. J Invest Derm 96: 281?284, 1991 (10.1111/1523-1747.ep12464485) / J Invest Derm by CE Klein (1991)
  16. Natali PG, Nicotra MR, Bartolazzi A, Cavaliere R, Bigotti A: Integrin expression in cutaneous malignant melanoma: association of the ?3/?1 heterodimer with tumor progression. Int J Cancer 54: 68?72, 1993 (10.1002/ijc.2910540112) / Int J Cancer by PG Natali (1993)
  17. Gehlsen KR, Davis GE, Sriramarao P: Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis 10: 111?120, 1992 (10.1007/BF00114587) / Clin Exp Metastasis by KR Gehlsen (1992)
  18. Elder DE, Rodeck U, Thurin J, Cardillo F, Jr WHC: Antigenic profile of tumor progression in human melanocytic nevi and melanomas. Cancer Res 49: 5091?5096, 1989 / Cancer Res by DE Elder (1989)
  19. deVries TJ, Quax PH, Denijn M, Verrijp KN, Verheijen JH, Verspaget HW, Weidle UH, Ruiter DJ, vanMuijen GNP: Plasminogen activators, their inhibitors and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Path 144: 70?81, 1994 / Am J Path by TJ deVries (1994)
  20. Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M, Buck CA: Integrin distribution in malignant melanoma: association of the ?3 subunit with tumor progression. Cancer Res 50: 6757?6764, 1990 / Cancer Res by SM Albelda (1990)
  21. Sanders LC, Felding-Habermann B, Mueller BM, Cheresh DA: Role of ?v integrins and vitronectin in human melanoma cell growth. Cold Spring Harbor Symposia on Quantitative Biology LVII: 233?240, 1992 (10.1101/SQB.1992.057.01.028) / Cold Spring Harbor Symposia on Quantitative Biology by LC Sanders (1992)
  22. Boukerche H, Benchaibi M, Berthier-Vergnes O, Lizard G, Bailly M, McGregor J: Two human melanoma cell-line variants with enhancedin vivo tumor growth and metastatic capacity do not express the ?3 integrin subunit. Eur J Biochem 220: 485?491, 1994 (10.1111/j.1432-1033.1994.tb18647.x) / Eur J Biochem by H Boukerche (1994)
  23. Brunner N, Pyke C, Hansen CH, Romer J, Grondahl-Hansen J, Dano K: Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer. Cancer Treat Res 71: 299?309, 1994 (10.1007/978-1-4615-2592-9_16) / Cancer Treat Res by N Brunner (1994)
  24. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161?187, 1993 (10.1152/physrev.1993.73.1.161) / Physiol Rev by P Mignatti (1993)
  25. Kwaan HC: The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 11: 291?311, 1992 (10.1007/BF01307184) / Cancer Metastasis Rev by HC Kwaan (1992)
  26. Delbaldo C, Masouye I, Saurat J-H, Vassalli J-D, Sappino A-P: Plasminogen activation in melanocytic neoplasia. Cancer Res 54: 4547?4552, 1994 / Cancer Res by C Delbaldo (1994)
  27. Blasi F: Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15: 105?111, 1993 (10.1002/bies.950150206) / Bioessays by F Blasi (1993)
  28. Bu G, Warshawsky I, Schwartz AL: Cellular receptors for the plasminogen activators. Blood 83: 3427?3436, 1994 (10.1182/blood.V83.12.3427.3427) / Blood by G Bu (1994)
  29. Felding-Habermann B, Cheresh DA: Vitronectin and its receptors. Curr Opin Cell Biol 5: 864?868, 1993 (10.1016/0955-0674(93)90036-P) / Curr Opin Cell Biol by B Felding-Habermann (1993)
  30. McCormick BA, Zetter BR: Adhesive interactions in angiogenesis and metastasis. Pharm Ther 53: 239?260, 1992 (10.1016/0163-7258(92)90011-N) / Pharm Ther by BA McCormick (1992)
  31. Albelda SM: Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 68: 4?17, 1993 / Lab Invest by SM Albelda (1993)
  32. Vleminckx K, Vakae LJ, Mareel M, Fiers W, van Roy F: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107?119, 1991 (10.1016/0092-8674(91)90143-M) / Cell by K Vleminckx (1991)
  33. Liotta L, Steeg P, Stetler-Stevenson W: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327?336, 1991 (10.1016/0092-8674(91)90642-C) / Cell by L Liotta (1991)
  34. Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann Rev Cell Biol 9: 541?573, 1993 (10.1146/annurev.cb.09.110193.002545) / Ann Rev Cell Biol by WG Stetler-Stevenson (1993)
  35. Werb Z, Tremble PM, Behrendtsen O, Crowley E, Damsky CH: Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 109: 877?889, 1989 (10.1083/jcb.109.2.877) / J Cell Biol by Z Werb (1989)
  36. Nicolson GL: Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res 204: 171?180, 1993 (10.1006/excr.1993.1022) / Exp Cell Res by GL Nicolson (1993)
  37. Juliano RL, Varner JA: Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 5: 812?818, 1993 (10.1016/0955-0674(93)90030-T) / Curr Opin Cell Biol by RL Juliano (1993)
  38. Marshall JF, Nesbitt SA, Helfrich MH, Horton MA, Polakova K, Hart IR: Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int J Cancer 49: 924?931, 1991 (10.1002/ijc.2910490621) / Int J Cancer by JF Marshall (1991)
  39. De Nichilo MO, Burns GF: Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate ?v integrin expression on cultured human macrophages. Proc Natl Acad Sci USA 90: 2517?2521, 1993 (10.1073/pnas.90.6.2517) / Proc Natl Acad Sci USA by MO Nichilo De (1993)
  40. Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, Mintz KA, Gehron RP, Teitelbaum SL, Cheresh DA: Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin ?v?3 potentiate bone resorption. J Biol Chem 268: 9901?9907, 1993 (10.1016/S0021-9258(18)98430-9) / J Biol Chem by FP Ross (1993)
  41. Horton M: Vitronectin receptor: tissue specific expression or adaptation to culture? Int J Exp Path 71: 741?759, 1990 / Int J Exp Path by M Horton (1990)
  42. Clyman RI, Mauray F, Kramer RH: ?1 and ?3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix. Exp Cell Res 200: 272?284, 1992 (10.1016/0014-4827(92)90173-6) / Exp Cell Res by RI Clyman (1992)
  43. Bianchine PJ, Burd RP, Metcalfe DD: IL-3-dependent mast cells attach to plate-bound vitronectin. Demonstration of augmented proliferation in response to signals transduced via cell surface vitronectin receptors. J Immunol 149: 3665?3671, 1992 (10.4049/jimmunol.149.11.3665) / J Immunol by PJ Bianchine (1992)
  44. Salcedo R, Patarroyo M: Constitutive ?v?3 integrin-mediated adhesion of human lymphoid B cells to vitronectin substrate. Cell Immunol 160: 165?172, 1995 (10.1016/0008-8749(95)80023-C) / Cell Immunol by R Salcedo (1995)
  45. Brando C, Shevach EM: Engagement of the vitronectin receptor (?v?3) on murine T cells stimulates tyrosine phosphorylation of a 115-kDa protein. J Immunol 154: 2005?2011, 1995 (10.4049/jimmunol.154.5.2005) / J Immunol by C Brando (1995)
  46. Rabinowich H, Lin WC, Amoscato A, Herberman RB, Whiteside TL: Expression of vitronectin receptor on human NK cells and its role in protein phosphorylation, cytokine production, and cell proliferation. J Immunol 154:1124?1135, 1995 (10.4049/jimmunol.154.3.1124) / J Immunol by H Rabinowich (1995)
  47. Lindsberg FP, Lublin DM, Telen MJ, Veile RA, Miller YE, Donis-Keller H, Brown EJ: Rh-related antigen CD47 is the signal-transducer integrin-associated protein. J Biol Chem 269: 1567?1570, 1994 (10.1016/S0021-9258(17)42058-8) / J Biol Chem by FP Lindsberg (1994)
  48. Bartfeld NS, Pasquale EB, Geltosky JE, Languino LR: The ?v?3 integrin associates with a 190-kDa protein that is phosphorylated on tyrosine in response to platelet-derived growth factor. J Biol Chem 268: 17270?17276, 1993 (10.1016/S0021-9258(19)85332-2) / J Biol Chem by NS Bartfeld (1993)
  49. Vuori K, Ruoslahti E: Association of insulin receptor substrate-1 with integrins. Science 266: 1576?1578, 1994 (10.1126/science.7527156) / Science by K Vuori (1994)
  50. Delannet M, Martin F, Bossy B, Cheresh DA, Reichardt LF, Duband J-L: Specific roles of the ?v?1, ?v?3 and ?v?5 integrins in avian neural crest cell adhesion and migration on vitronectin. Development 120: 2687?2702, 1994 (10.1242/dev.120.9.2687) / Development by M Delannet (1994)
  51. Brooks PC, Clark RAF, Cheresh DA: Requirement of vascular integrin ?v?3 for angiogenesis. Science 264: 569?571, 1994 (10.1126/science.7512751) / Science by PC Brooks (1994)
  52. Leavesley DI, Ferguson GD, Wayner EA, Cheresh DA: Requirement of the integrin ?3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol 117: 1101?1107, 1992 (10.1083/jcb.117.5.1101) / J Cell Biol by DI Leavesley (1992)
  53. Gailit J, Welch MP, Clark RAF: TGF-?1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J Invest Derm 103: 221?227, 1994 (10.1111/1523-1747.ep12393176) / J Invest Derm by J Gailit (1994)
  54. Brown SL, Lundgren CH, Nordt T, Fujii S: Stimulation of migration of human aortic smooth muscle cells by vitronectin- implications for atherosclerosis. Cardiovascular Res 28: 1815?1820, 1994 (10.1093/cvr/28.12.1815) / Cardiovascular Res by SL Brown (1994)
  55. Felding-Habermann B, Mueller BM, Romerdahl CA, Cheresh DA: Involvement of integrin ?V gene expression in human melanoma tumorigenicity. J Clin Invest 89: 2018?2022, 1992 (10.1172/JCI115811) / J Clin Invest by B Felding-Habermann (1992)
  56. Montgomery AMP, Reisfeld RA, Cheresh DA: Integrin ?v?3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA 91: 8856?8860, 1994 (10.1073/pnas.91.19.8856) / Proc Natl Acad Sci USA by AMP Montgomery (1994)
  57. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin ?v?3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157?1164, 1994 (10.1016/0092-8674(94)90007-8) / Cell by PC Brooks (1994)
  58. Seftor REB, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E, Hendrix MJC: Role of ?v?3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 89: 1557?1561, 1992 (10.1073/pnas.89.5.1557) / Proc Natl Acad Sci USA by REB Seftor (1992)
  59. Davis GE: Affinity of integrins for damaged extracellular matrix: ?v?3 binds to denatured collagen type I through RGD sites. Biochem Biophys Res Comm 182: 1025?1031, 1992 (10.1016/0006-291X(92)91834-D) / Biochem Biophys Res Comm by GE Davis (1992)
  60. Vassalli J-D, Sappino A-P, Belin D: The plasminogen activator/plasmin system. J Clin Invest 88: 1067?1072, 1991 (10.1172/JCI115405) / J Clin Invest by J-D Vassalli (1991)
  61. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB: Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J Cell Biol 118: 901?909, 1992 (10.1083/jcb.118.4.901) / J Cell Biol by R Flaumenhaft (1992)
  62. Skriver L, Nielsen LS, Stephens R, Danø K: Plasminogen activator released as inactive proenzyme from sarcoma virus transformed murine cells. Eur J Biochem 124: 409?414, 1982 (10.1111/j.1432-1033.1982.tb06608.x) / Eur J Biochem by L Skriver (1982)
  63. Ellis V, Danø K: Plasminogen activation by receptor-bound urokinase. Sem Thromb Hemostasis 17: 194?200, 1991 (10.1055/s-2007-1002609) / Sem Thromb Hemostasis by V Ellis (1991)
  64. Heeb MJ, Espana F, Geiger M, Collen D, Stump DC, Griffin JH: Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3. J Biol Chem 262: 15813?15816, 1987 (10.1016/S0021-9258(18)47659-4) / J Biol Chem by MJ Heeb (1987)
  65. Kruithof EK: Plasminogen activator inhibitors - a review. Enzyme 40: 113?121, 1988 (10.1159/000469153) / Enzyme by EK Kruithof (1988)
  66. Seiffert D, Mimuro J, Schleef RR, Loskutoff DJ: Interactions between type I plasminogen activator inhibitor, extracellular matrix and vitronectin. Cell Diff Dev 32: 287?292, 1990 (10.1016/0922-3371(90)90041-T) / Cell Diff Dev by D Seiffert (1990)
  67. Ciambrone GJ, McKeown-Longo PJ: Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells. J Cell Biol 111: 2183?2195, 1990 (10.1083/jcb.111.5.2183) / J Cell Biol by GJ Ciambrone (1990)
  68. Blasi F: Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15: 105?111, 1993 (10.1002/bies.950150206) / Bioessays by F Blasi (1993)
  69. Herz J, Clouthier DE, Hammer RE: LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 71: 411, 1992 (10.1016/0092-8674(92)90511-A) / Cell by J Herz (1992)
  70. Olson D, Pollanen J, Hoyer-Hansen G, Ronne E, Sakaguchi K, Wun T-C, Appella E, Danø K, Blasi F: Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the uPAR. J Biol Chem 267: 9129, 1992 (10.1016/S0021-9258(19)50398-2) / J Biol Chem by D Olson (1992)
  71. Bu G, Warshawsky I, Schwartz AL: Cellular receptors for plasminogen activators. Blood 83: 3427?3436, 1994 (10.1182/blood.V83.12.3427.3427) / Blood by G Bu (1994)
  72. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA: Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269: 32380?32388, 1994 (10.1016/S0021-9258(18)31646-6) / J Biol Chem by Y Wei (1994)
  73. Grondahl-Hansen J, Ralfkiaer E, Kirkeby LT, Kristensen P, Lund LR, Dano K: Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Path 138: 111?117, 1991 / Am J Path by J Grondahl-Hansen (1991)
  74. Pyke C, Kirstensen P, Ralfkiaer E, Grondahl-Hansen J, Eriksen J, Blasi F, Dano K: Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Path 138: 1059?1067, 1991 / Am J Path by C Pyke (1991)
  75. Lund LR, Rømer J, Rønne E, Ellis V, Blasi F, Danø K: Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor ?1 in human A549 lung carcinoma cells. EMBO J 10: 3399?3407, 1991 (10.1002/j.1460-2075.1991.tb04904.x) / EMBO J by LR Lund (1991)
  76. Shattil S, Haimovich B, Cunningham M, Lipfert L, Parsons J, Ginsberg M, Brugge JS: Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors. J Biol Chem 269: 14738?14745, 1994 (10.1016/S0021-9258(17)36687-5) / J Biol Chem by S Shattil (1994)
  77. Davis CM, Danehower SC, Laurenza A, Molony JL: Identification of a role of the vitronectin receptor and protein kinase C in the induction of endothelial cell vascular formation. J Cell Biochem 51: 206?218, 1993 (10.1002/jcb.240510213) / J Cell Biochem by CM Davis (1993)
  78. Liu B, Renaud C, Nelson KK, Chen YQ, Bazaz R, Kowynia J, Timar J, Diglio CA, Honn KV: Protein-kinase-C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonization. Int J Cancer 52: 147?152, 1992 (10.1002/ijc.2910520126) / Int J Cancer by B Liu (1992)
  79. Nip J, Shibata H, Loskutoff DJ, Cheresh DA, Brodt P: Human melanoma cells derived from lymphatic metastases use integrin ?v?3 to adhere to lymph node vitronectin. J Clin Invest 90: 1406?1413, 1992 (10.1172/JCI116007) / J Clin Invest by J Nip (1992)
  80. Nip J, Rabbani SA, Shibata H, Brodt P: Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells. J Clin Invest 95: 2096?2103, 1995 (10.1172/JCI117897) / J Clin Invest by J Nip (1995)
  81. Saksela O, Hovi T, Vaheri A: Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages. J Cell Physiol 122: 125?132, 1985 (10.1002/jcp.1041220119) / J Cell Physiol by O Saksela (1985)
  82. Waltz DA, Chapman HA: Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem 269: 14746?14750, 1994 (10.1016/S0021-9258(17)36688-7) / J Biol Chem by DA Waltz (1994)
  83. Miyamoto S, Akiyama SK, Yamada KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 267: 883?885, 1995 (10.1126/science.7846531) / Science by S Miyamoto (1995)
  84. Sanchez-Mateos P, Arroyo AG, Balboa MA, Sanchez-Madrid F: Post-receptor occupancy events in leukocytes during ? 1 integrin-ligand interactions. Eur J Immunol 23: 2642?2648, 1993 (10.1002/eji.1830231038) / Eur J Immunol by P Sanchez-Mateos (1993)
  85. Pelletier AJ, Bodary SC, Levinson AD: Signal transduction by the platelet integrin ?IIb ?3: induction of calcium oscillations required for protein-tyrosine phosphorylation and ligand-induced spreading of stably transfected cells. Mol Biol Cell 3: 989?998, 1992 (10.1091/mbc.3.9.989) / Mol Biol Cell by AJ Pelletier (1992)
  86. Yurochko AD, Liu DY, Eierman D, Haskill S: Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc Natl Acad Sci USA 899034-8: 9034?8, 1992 (10.1073/pnas.89.19.9034) / Proc Natl Acad Sci USA by AD Yurochko (1992)
  87. Mattei S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M: Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56: 853?857, 1994 (10.1002/ijc.2910560617) / Int J Cancer by S Mattei (1994)
  88. Rodeck U, Bossler A, Graeven U, Fox FE, Nowell PC, Knabbe C, Kari C: Transforming growth factor ? production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res 54: 575?581, 1994 / Cancer Res by U Rodeck (1994)
  89. Leavesley DI, Schwartz MA, Rosenfeld M, Cheresh DA: Integrin ?1- and ?3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 121: 163?170, 1993 (10.1083/jcb.121.1.163) / J Cell Biol by DI Leavesley (1993)
  90. Seftor RE, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E, Hendrix MJ: Role of the ?v?3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 89: 1557?1561, 1992 (10.1073/pnas.89.5.1557) / Proc Natl Acad Sci USA by RE Seftor (1992)
  91. Stahl A, Mueller BM: Binding of urokinase to its receptor promotes migration and invasion of human melanoma cellsin vitro. Cancer Res 54: 3066?3071, 1994 / Cancer Res by A Stahl (1994)
  92. Odekon LE, Blasi F, Rifkin DB: Requirement for receptorbound urokinase in plasmin-dependent cellular conversion of latent TGF-? to TGF-?. J Cell Physiol 158: 398?407, 1994 (10.1002/jcp.1041580303) / J Cell Physiol by LE Odekon (1994)
  93. Pepper MS, Sappino A-P, Stöcklin R, Montesano R, Orci L, Vassalli J-D: Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 122: 673?684, 1993 (10.1083/jcb.122.3.673) / J Cell Biol by MS Pepper (1993)
  94. Kerbel RS: Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm. Am J Path 141: 519?524, 1992 / Am J Path by RS Kerbel (1992)
  95. Brodt P: Adhesion mechanisms in lymphatic metastasis. Cancer Metastasis Rev 10: 23?32, 1991 (10.1007/BF00046841) / Cancer Metastasis Rev by P Brodt (1991)
  96. Kramer RH, Rose SD, McDonald KA: Basement membrane components associated with the extracellular matrix of the lymph nodes. Cell Tissue Res 252: 367?375, 1988 (10.1007/BF00214379) / Cell Tissue Res by RH Kramer (1988)
  97. Simonton SC, Basara ML, Barnes DN, Furch LT: Distribution and immunolocalization of serum spreading factor in human tissue. Lab Invest 52: 63, 1985 / Lab Invest by SC Simonton (1985)
  98. Reilly JT, Nash JRG: Vitronectin (serum spreading factor): its localisation in normal and fibrotic tissue. J Clin Path 41: 1269?1272, 1988 (10.1136/jcp.41.12.1269) / J Clin Path by JT Reilly (1988)
  99. Meissauer A, Kramer MD, Schirrmacher V, Brunner G: Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasivenessin vitro. Exp Cell Res 199: 179?190, 1992 (10.1016/0014-4827(92)90423-6) / Exp Cell Res by A Meissauer (1992)
  100. Wayner EA, Orlando RA, Cheresh DA: Integrins ?v?3 and ?v?5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J Cell Biol 113: 919?929, 1991 (10.1083/jcb.113.4.919) / J Cell Biol by EA Wayner (1991)
  101. Weitzman JB, Pasqualini R, Takada Y, Hemler ME: The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation. J Biol Chem 268: 8651?8657, 1993 (10.1016/S0021-9258(18)52924-0) / J Biol Chem by JB Weitzman (1993)
Dates
Type When
Created 20 years, 9 months ago (Nov. 30, 2004, 7:45 a.m.)
Deposited 2 years, 4 months ago (April 30, 2023, 12:07 p.m.)
Indexed 1 month, 2 weeks ago (July 12, 2025, 6:48 p.m.)
Issued 29 years, 11 months ago (Sept. 1, 1995)
Published 29 years, 11 months ago (Sept. 1, 1995)
Published Print 29 years, 11 months ago (Sept. 1, 1995)
Funders 0

None

@article{Nip_1995, title={The role of the integrin vitronectin receptor, ?v?3 in melanoma metastasis}, volume={14}, ISSN={1573-7233}, url={http://dx.doi.org/10.1007/bf00690295}, DOI={10.1007/bf00690295}, number={3}, journal={Cancer and Metastasis Reviews}, publisher={Springer Science and Business Media LLC}, author={Nip, John and Brodt, Pnina}, year={1995}, month=sep, pages={241–252} }